Edit System Optimization
With targeted and unbiased assays, you can assess the efficacy of your new genome editing system.
Demonstrate the Power of Your Editing System
Unlock the future of gene editing with precision and confidence.
Novel approaches to gene editing are breaking new ground for therapeutics development. With KromaTiD’s innovative directional Genomic Hybridization (dGHTM) technology, you can visualize small inversions, complex rearrangements, and evidence of genomic instability, measuring edit system performance throughout development.
Unique to KromaTiD, we can design custom single-cell assays to evaluate systems of samples, analyzing translocations, centromere abnormalities, chromothripsis, gains/losses, and truncations. This provides unparalleled insight into your editing method’s performance.